Skip to main content
Clinical Trials/NL-OMON26563
NL-OMON26563
Not yet recruiting
Not Applicable

The perioperative renal and metabolic outcomes after sodium glucose cotransporter 2 inhibitor in cardiac surgery – an open-label phase IV randomized controlled trial

Amsterdam UMC location AMC0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac surgery associated acute kidney injury
Sponsor
Amsterdam UMC location AMC
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC location AMC

Eligibility Criteria

Inclusion Criteria

  • 18 to 90 years old (inclusive)
  • Undergoing elective cardiac surgery with cardio\-pulmonary bypass.
  • Providing informed consent

Exclusion Criteria

  • Current treatment with SGLT2 inhibitors.
  • Diabetes Mellitus Type 1
  • BMI\<25 for people with type 2 diabetes
  • Reduced renal function at baseline with eGFR \< 30 ml/min.
  • Systolic blood pressure \< 100 mmHg at time of inclusion.
  • Emergency surgery, defined as in need of surgery for medical reasons \< 7 days, i.e. S1\-4” according to the Amsterdam UMC classification.
  • Female of child\-bearing potential who is pregnant, breast\-feeding or intend to become pregnant or is not using adequate contraceptive methods.
  • Known or suspected allergy to trial products or other drugs in the same class.

Outcomes

Primary Outcomes

Not specified

Similar Trials